Sandoz Group AG
SDZ.SW
| Exchange: | SW |
| Currency | Swiss Franc |
| Open Figi: | BBG01J3DD3T3 |
| ISIN: | CH1243598427 |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Drug Manufacturers - Specialty & Generic |
| Description: | Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease. It also provides a portfolio of active pharmaceutical ingredients and finished dosage forms. The company was founded in 1886 and is headquartered in Basel, Switzerland. |
| Address: | Forum 1, Basel, Switzerland, 4056 |
| Website: | https://www.sandoz.com |
| Full Time Employees: | 22633 |
| Updated On: | 2024-11-05 |
Highlights
| Market Capitalization: | 17175663616 |
| Market Capitalization Mln: | 17175.66 |
| EBITDA: | 642000000 |
| PEG Ratio: | 0.83 |
| Wall Street Target Price: | 37.09 |
| Book Value: | 19.44 |
| Dividend Share: | 0.53 |
| Dividend Yield: | 0.01 |
| Earnings Share: | -0.02 |
| EPS Estimate Next Year: | 2.39 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | -0.00 |
| Operating Margin TTM: | 0.06 |
| Return On Equity TTM: | -0.00 |
| Revenue TTM: | 10110999552 |
| Revenue Per Share TTM: | 23.51 |
| Quarterly Revenue Growth YOY: | 0.02 |
| Gross Profit TTM: | 4378000000 |
| Diluted Eps TTM: | -0.02 |
| Quarterly Earnings Growth YOY: | -0.36 |
Valuation
| Forward PE: | 14.00 |
| Price Sales TTM: | 1.69 |
| Price Book MRQ: | 2.38 |
| Enterprise Value: | 17003116908 |
| Enterprise Value Revenue: | 1.93 |
| Enterprise Value Ebitda: | 25.98 |
Shares
| Shares Outstanding: | 429928992 |
| Shares Float: | 412247754 |
| Percent Insiders: | 4.16 |
| Percent Institutions: | 44.54 |
Technicals
| 52 Week High: | 40.5 |
| 52 Week Low: | 23.08 |
| 50 Day MA: | 36.58 |
| 200 Day MA: | 32.54 |
Splits & Dividends
| Forward Annual Dividend Rate: | 0.45 |
| Forward Annual Dividend Yield: | 0.01 |
| Dividend Date: | 2024-05-07 |
| Ex Dividend Date: | 2024-05-03 |
Earnings
| Report Date: | 2025-03-05 |
| Date: | 2024-12-31 |
| Before After Market: | Before Market |
| Report Date: | 2024-10-30 |
| Date: | 2024-09-30 |
| Before After Market: | Before Market |
| Date: | 2024-12-31 |
| Period: | +1y |
| Earnings Estimate Avg: | 2.39 |
| Earnings Estimate Low: | 1.85 |
| Earnings Estimate High: | 2.64 |
| Earnings Estimate Number Of Analysts: | 15.00 |
| Revenue Estimate Avg: | 9163180000.00 |
| Revenue Estimate Low: | 9046210000.00 |
| Revenue Estimate High: | 9424250000.00 |
| Revenue Estimate Number Of Analysts: | 14.00 |
| Revenue Estimate Growth: | 0.05 |
| Eps Trend Current: | 2.39 |
| Eps Trend7days Ago: | 2.41 |
| Eps Trend30days Ago: | 2.41 |
| Eps Trend60days Ago: | 2.46 |
| Eps Trend90days Ago: | 2.46 |
| Date: | 2024-03-31 |
| Period: | +1q |
| Date: | 2023-12-31 |
| Revenue Estimate Avg: | 8662210000.00 |
| Revenue Estimate Low: | 8437220000.00 |
| Revenue Estimate High: | 8880810000.00 |
| Revenue Estimate Number Of Analysts: | 14.00 |
| Eps Trend7days Ago: | 1.98 |
| Eps Trend30days Ago: | 1.98 |
| Eps Trend60days Ago: | 2.03 |
| Eps Trend90days Ago: | 2.03 |
| Eps Revisions Up Last30days: | 1.00 |
| Eps Revisions Down Last30days: | 3.00 |
| Date: | 2024-09-30 |